The Glucose Dependent Insulinotropic Polypeptide Agonist Market is gaining significant traction within the pharmaceutical industry, particularly in the field of diabetes management. The demand for novel therapeutic agents that can efficiently manage glucose levels is on the rise, driven by the global prevalence of diabetes. Among the promising therapeutic approaches, Glucose Dependent...